Praxis Precision Medicines Inc. (PRAX) PT Raised to $1,200 at Piper Sandler on 'Major Upside Potential'
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi raised the price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX) to $1,200.00 (from $450.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
